Table 2.
Model | Type | Tissue sites | Effects | Mechanisms | RF |
---|---|---|---|---|---|
Endothelin-1-induced focal cerebral ischemia in rats | In vivo | Focal cerebral ischemia injury | ↑ number and length of crossing CST fibers ↑ PSD95 and VGlut-1 levels ↑ number of BrdU+/DCX+ cells ↓ rho-A+, ROCK+, Nogo-A+ and Nogo-R+ cells ↑ behavioral performance |
↑ axonal growth ↑ neurogenesis |
[53] |
p MCAO in rats | In vivo | Cerebral ischemia infarction | ↓ glucose and citric acid levels ↑ ATP, ADP, AMP, and GMP metabolism ↑ glutamate, glutamine, aspartate, and N-acetylaspartate levels ↑ glutathione, ascorbic acid, and taurine levels ↓ number of sodium ions ↑ number of potassium ions |
↑ ATP metabolism ↑ antioxidant level Maintain sodium-potassium ion balance |
[52] |
Endothelin-1-induced focal cerebral ischemia in rats | In vivo | Stroke-induced white matter injury | ↑ differentiation and maturation of OPCs ↑ length of CST fibers into the denervated hemispheres |
↑ Remyelination ↑ BDNF level ↓ NogoA level |
[57] |
OGD in cortical neurons | In vitro | Ischemic stroke | ↑ number of primary and secondary dendrites and of dendritic tips | Regulate dendritic branching ↓ PI3K/AKT Signaling |
[54] |
p MCAO in mice | In vivo | Cerebral infarction | ↓ neurologic function deficits ↓ infarction volume ↓ BBB permeability ↓ MMP-9 expression ↑ Claudin-5 expression |
↑ VEGF and GFAP expression ↑ ultrastructure in capillary Endothelial cells of BBBs ↑ Nrf-2/HO-1 signaling pathway |
[47] |
MCAO in rats | In vivo | Cerebral ischemia | ↑ body weight ↓ infarct volume ↑ neurobehavioral outcomes ↑ number of CD31+ microvessels ↑ number of CD31+/BrdU+ proliferating endothelial cells ↑ functional Vascular density ↑ VEGF level ↑ angiopoietin-1 level |
↑ angiogenesis ↑ sonic hedgehog expression |
[55] |
MCAO in mice Photothrombosis-induced permanent cerebral ischemia in mice |
In vivo | Ischemic stroke | ↓ ICAM-1 level ↓ PAR-1 level ↓ brain infiltration of myeloid cells Preserve BBB integrity ↑ cerebral blood flow |
↓ neurovascular inflammation | [48] |
t MCAO in mice | In vivo | Cerebral I/R injury | ↓ infarct volume ↓ neurological deficit ↓ cerebral edema ↓ BBB permeability |
↑ blood flow ↓ BBB dysfunction |
[49] |
ADP, thrombin, U46619, AA, and collagen-induced platelet activation in human | In vivo | Arterial thrombotic diseases heart attack and stroke | ↓ human platelet Aggregation and ATP release PAC-1 binding ↓ TXA2 synthesis ↓ intracellular calcium mobilization |
↓ cPLA2-mediated TXA2 synthesis ↓ PDE level ↑ 3,5-cyclic adenosine monophosphate level |
[51] |
BCCAO in rats | In vivo | Chronic cerebral hypoperfusion | ↑ CBF recovery ↑ hemodynamic compensation ↓ astrogliosis ↓ cell apoptosis Protect hippocampal neurons |
↑ hemodynamics ↑ CBF recovery ↑ cognitive function |
[50] |
MCAO in mice | In vivo | Ischemic stroke | ↑ functional recovery ↑ number of RECA-1 positive vessels ↑ occludin expression ↑ HIF-1α expression ↑ VEGF, notch, and DLL-4 expression |
↑ white matter integrity, ↑ occludin expression ↑ HIF-1α/VEGF/notch/Dll4 expression |
[64] |
OGD in SV40-transformed aortic rat endothelial cell line | In vitro | Ischemic injury | ↓ endothelial cells injury ↑ PGC-1α expression ↑ vascular proliferation |
Maintain the endothelial PGC-1α expression via regulating eNOS activity |
[56] |
RF: reference; other abbreviations as shown in the literature. (↓): downregulation or inhibition; (↑): upregulation or activation.